Pyridine-3,5-dicarboxylic acid monoethyl ester, 97.0%, 250mg

(3-Methyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-acetic acid, 95.0%, 1g

Magnesium acetate tetrahydrate, min. 98%, pa, ACS, 500 g, plastic packaging.

tert-Butyl o-tolylcarbamate, 95.0%, 250mg

Ethyl 6-oxo-2-(trifluoromethyl)-1,4,5,6-tetrahydro-3-pyridinecarboxylate, 95.0%, 250mg

Diethyl Cyanomethylphosphonate>98.0%(GC)25g

2-BROMO-4-IODODIBENZO[B,D]FURAN, 95%, 5g

2-(3-HYDROXYCYCLOHEXYL)ISOINDOLINE-1,3-DIONE, 95.0%, 500mg

2-Chloro-N-(4-methylthiophenyl)-acetamide, 95.0%, 1g

Sodium hydroxide solution 40%, extra pure, 1 l, plastic packaging.

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 5g

GC capillary column ROTI®Cap-FFAP, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

1,3,5-Tris(4-formylphenyl)benzene>96.0%(HPLC)200mg